{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:42:13Z","timestamp":1792791733684,"version":"4.5.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.lungcan.2026.109650","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T15:47:04Z","timestamp":1791992824000},"page":"109650","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Exosomal miR-3662 originating from M2-polarized macrophages facilitates cisplatin resistance of lung adenocarcinoma cells through inhibiting the IRF8\/RASSF5 cascade and boosting autophagy"],"prefix":"10.1016","volume":"222","author":[{"given":"Fengqiang","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiazhou","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanlong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbo","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menglong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sizhe","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fancai","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.lungcan.2026.109650_b0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109650_b0010","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109650_b0015","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41572-024-00551-9","article-title":"Non-small-cell lung cancer","volume":"10","author":"Hendriks","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"10299","key":"10.1016\/j.lungcan.2026.109650_b0020","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","article-title":"Lung cancer","volume":"398","author":"Thai","year":"2021","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.lungcan.2026.109650_b0025","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jtho.2021.11.003","article-title":"The 2021 WHO classification of lung tumors: impact of advances since 2015","volume":"17","author":"Nicholson","year":"2022","journal-title":"J. Thorac. Oncol."},{"issue":"4","key":"10.1016\/j.lungcan.2026.109650_b0030","doi-asserted-by":"crossref","first-page":"249","DOI":"10.6004\/jnccn.2204.0023","article-title":"Non-small cell lung cancer, version 4.2024, NCCN clinical practice guidelines in oncology","volume":"22","author":"Riely","year":"2024","journal-title":"J. Natl. Compr. Canc. Netw."},{"issue":"10308","key":"10.1016\/j.lungcan.2026.109650_b0035","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S0140-6736(21)02098-5","article-title":"Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial","volume":"398","author":"Felip","year":"2021","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.lungcan.2026.109650_b0040","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1056\/NEJMoa2202170","article-title":"Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer","volume":"386","author":"Forde","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109650_b0045","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41568-020-00308-y","article-title":"The rediscovery of platinum-based cancer therapy","volume":"21","author":"Rottenberg","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"46","key":"10.1016\/j.lungcan.2026.109650_b0050","doi-asserted-by":"crossref","first-page":"6395","DOI":"10.1038\/s41388-021-02055-2","article-title":"A highly annotated database of genes associated with platinum resistance in cancer","volume":"40","author":"Huang","year":"2021","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.lungcan.2026.109650_b0055","doi-asserted-by":"crossref","first-page":"4960","DOI":"10.1038\/s41467-021-24845-8","article-title":"Cisplatin-mediated activation of glucocorticoid receptor induces platinum resistance via MAST1","volume":"12","author":"Pan","year":"2021","journal-title":"Nat. Commun."},{"issue":"16","key":"10.1016\/j.lungcan.2026.109650_b0060","doi-asserted-by":"crossref","first-page":"8885","DOI":"10.3390\/ijms22168885","article-title":"Molecular mechanisms of chemoresistance induced by cisplatin in NSCLC cancer therapy","volume":"22","author":"Kryczka","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lungcan.2026.109650_b0065","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2147\/JEP.S267383","article-title":"Advances in our understanding of the molecular mechanisms of action of cisplatin in cancer therapy","volume":"13","author":"Tchounwou","year":"2021","journal-title":"J. Exp. Pharmacol."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109650_b0070","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"issue":"3","key":"10.1016\/j.lungcan.2026.109650_b0075","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth","volume":"41","author":"De","year":"2023","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.lungcan.2026.109650_b0080","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41568-022-00547-1","article-title":"A timeline of tumour-associated macrophage biology","volume":"23","author":"Cassetta","year":"2023","journal-title":"Nat. Rev. Cancer"},{"issue":"11","key":"10.1016\/j.lungcan.2026.109650_b0085","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","article-title":"Macrophages as tools and targets in cancer therapy","volume":"21","author":"Mantovani","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"9","key":"10.1016\/j.lungcan.2026.109650_b0090","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41423-023-01061-6","article-title":"Roles of macrophages in tumor development: a spatiotemporal perspective","volume":"20","author":"Bied","year":"2023","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109650_b0095","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41392-021-00506-6","article-title":"Targeting macrophages in cancer immunotherapy","volume":"6","author":"Duan","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"13","key":"10.1016\/j.lungcan.2026.109650_b0100","doi-asserted-by":"crossref","first-page":"6995","DOI":"10.3390\/ijms22136995","article-title":"Macrophage polarization states in the tumor microenvironment","volume":"22","author":"Boutilier","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lungcan.2026.109650_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116930","article-title":"Macrophage polarization in the tumor microenvironment: emerging roles and therapeutic potentials","volume":"177","author":"Zhang","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109650_b0110","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41392-021-00484-9","article-title":"Targeting tumor-associated macrophages to synergize tumor immunotherapy","volume":"6","author":"Xiang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"8","key":"10.1016\/j.lungcan.2026.109650_b0115","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.cell.2023.03.010","article-title":"The role of extracellular vesicles in cancer","volume":"186","author":"Kalluri","year":"2023","journal-title":"Cell"},{"issue":"6478","key":"10.1016\/j.lungcan.2026.109650_b0120","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.lungcan.2026.109650_b0125","article-title":"Extracellular vesicles and particles impact the systemic landscape of cancer","volume":"41","author":"Lucotti","year":"2022","journal-title":"EMBO J."},{"issue":"2","key":"10.1016\/j.lungcan.2026.109650_b0130","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J. Extracell. Vesicles"},{"issue":"25","key":"10.1016\/j.lungcan.2026.109650_b0135","article-title":"Extracellular vesicles in cancer drug resistance: roles, mechanisms, and implications for cancer therapy","volume":"9","author":"Yang","year":"2022","journal-title":"Adv. Sci. (Weinh)"},{"issue":"3","key":"10.1016\/j.lungcan.2026.109650_b0140","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1152\/physrev.00019.2024","article-title":"The influence of extracellular vesicles on tumor evolution and resistance to therapy","volume":"105","author":"Baston","year":"2025","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109650_b0145","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12943-022-01650-5","article-title":"Mesenchymal stem cell-derived exosomes in cancer therapy resistance: recent advances and therapeutic potential","volume":"21","author":"Lin","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.lungcan.2026.109650_b0150","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.2147\/IJN.S131516","article-title":"Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in an exosomal miR-100-5p-dependent manner","volume":"12","author":"Qin","year":"2017","journal-title":"Int. J. Nanomed."},{"issue":"3","key":"10.1016\/j.lungcan.2026.109650_b0155","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.21037\/tlcr-20-1255","article-title":"Tumor-associated macrophages secret exosomal miR-155 and miR-196a-5p to promote metastasis of non-small-cell lung cancer","volume":"10","author":"Li","year":"2021","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.lungcan.2026.109650_b0160","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1683799","article-title":"Targeting cancer via macrophage-derived exosomal miRNAs: implications for tumor progression and resistance","volume":"16","author":"Ramalingam","year":"2025","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.lungcan.2026.109650_b0165","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41576-023-00611-y","article-title":"microRNAs in action: biogenesis, function and regulation","volume":"24","author":"Shang","year":"2023","journal-title":"Nat. Rev. Genet."},{"issue":"2","key":"10.1016\/j.lungcan.2026.109650_b0170","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.lungcan.2026.109650_b0175","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1038\/s12276-023-01050-9","article-title":"MicroRNA: trends in clinical trials of cancer diagnosis and therapy strategies","volume":"55","author":"Kim","year":"2023","journal-title":"Exp. Mol. Med."},{"issue":"6","key":"10.1016\/j.lungcan.2026.109650_b0180","doi-asserted-by":"crossref","first-page":"e1662","DOI":"10.1002\/wrna.1662","article-title":"microRNA-based diagnostic and therapeutic applications in cancer medicine","volume":"12","author":"Sempere","year":"2021","journal-title":"Wiley Interdiscip. Rev.: RNA"},{"issue":"1","key":"10.1016\/j.lungcan.2026.109650_b0185","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13046-025-03391-x","article-title":"MicroRNA in cancer therapy: breakthroughs and challenges in early clinical applications","volume":"44","author":"Di","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2026.109650_b0190","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.736323","article-title":"MicroRNA as an important target for anticancer drug development","volume":"12","author":"Fu","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.lungcan.2026.109650_b0195","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00280-021-04289-z","article-title":"MiRNA-3662 reverses the gemcitabine resistance in pancreatic cancer through regulating the tumor metabolism","volume":"88","author":"Liu","year":"2021","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"4","key":"10.1016\/j.lungcan.2026.109650_b0200","doi-asserted-by":"crossref","first-page":"773","DOI":"10.4149\/neo_2020_190730N689","article-title":"MiR-3662 suppresses cell growth, invasion and glucose metabolism by targeting HK2 in hepatocellular carcinoma cells","volume":"67","author":"Ye","year":"2020","journal-title":"Neoplasma"},{"issue":"2","key":"10.1016\/j.lungcan.2026.109650_b0205","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41388-021-02089-6","article-title":"CRISPR interference and activation of the microRNA-3662-HBP1 axis control progression of triple-negative breast cancer","volume":"41","author":"Yi","year":"2022","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.lungcan.2026.109650_b0210","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s10238-025-01861-2","article-title":"miR-3662 targets CAB39L to promote proliferation and invasion in gastric cancer","volume":"25","author":"Huang","year":"2025","journal-title":"Clin. Exp. Med."},{"issue":"3","key":"10.1016\/j.lungcan.2026.109650_b0215","doi-asserted-by":"crossref","first-page":"749","DOI":"10.4103\/jcrt.jcrt_280_21","article-title":"Detection significance of miR-3662, miR-146a, and miR-1290 in serum exosomes of breast cancer patients","volume":"17","author":"Li","year":"2021","journal-title":"J. Cancer Res. Ther."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109650_b0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15548627.2020.1797280","article-title":"Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)","volume":"17","author":"Klionsky","year":"2021","journal-title":"Autophagy"},{"issue":"5","key":"10.1016\/j.lungcan.2026.109650_b0225","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.tips.2023.02.003","article-title":"Recent advances in targeting autophagy in cancer","volume":"44","author":"Jain","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"issue":"8","key":"10.1016\/j.lungcan.2026.109650_b0230","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41580-023-00585-z","article-title":"Autophagy and autophagy-related pathways in cancer","volume":"24","author":"Debnath","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"10","key":"10.1016\/j.lungcan.2026.109650_b0235","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/s41419-023-06154-8","article-title":"Autophagy: regulator of cell death","volume":"14","author":"Liu","year":"2023","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.lungcan.2026.109650_b0240","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1158\/2159-8290.CD-19-0292","article-title":"Targeting autophagy in cancer: recent advances and future directions","volume":"9","author":"Amaravadi","year":"2019","journal-title":"Cancer Discov."},{"issue":"13","key":"10.1016\/j.lungcan.2026.109650_b0245","doi-asserted-by":"crossref","first-page":"7459","DOI":"10.3390\/ijms25137459","article-title":"Blockage of autophagy for cancer therapy: a comprehensive review","volume":"25","author":"Hassan","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.lungcan.2026.109650_b0250","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.3390\/biomedicines10071596","article-title":"Molecular mechanisms of autophagy in cancer development, progression, and therapy","volume":"10","author":"Vitto","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.lungcan.2026.109650_b0255","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1528230","article-title":"The role of autophagy in cancer: from molecular mechanism to therapeutic window","volume":"16","author":"Jalali","year":"2025","journal-title":"Front. Immunol."},{"issue":"13","key":"10.1016\/j.lungcan.2026.109650_b0260","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021110031","article-title":"The multifaceted role of autophagy in cancer","volume":"41","author":"Russell","year":"2022","journal-title":"EMBO J."},{"key":"10.1016\/j.lungcan.2026.109650_b0265","article-title":"Crosstalk between autophagy and immune cell infiltration in the tumor microenvironment","volume":"10","author":"Yang","year":"2023","journal-title":"Front. Med. (Lausanne)"},{"issue":"17","key":"10.1016\/j.lungcan.2026.109650_b0270","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.3390\/cells11172630","article-title":"IRF8: mechanism of action and health implications","volume":"11","author":"Moorman","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.lungcan.2026.109650_b0275","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1186\/s12967-024-05519-7","article-title":"IRF8 deficiency-induced myeloid-derived suppressor cell promote immune evasion in lung adenocarcinoma","volume":"22","author":"Gao","year":"2024","journal-title":"J. Transl. Med."},{"issue":"8","key":"10.1016\/j.lungcan.2026.109650_b0280","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.immuni.2022.06.006","article-title":"IRF8 deficiency induces the transcriptional, functional, and epigenetic reprogramming of cDC1 into the cDC2 lineage","volume":"55","author":"Lan\u00e7a","year":"2022","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.lungcan.2026.109650_b0285","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3390\/cells12020310","article-title":"IRF8 regulates intrinsic ferroptosis through repressing p53 expression to maintain tumor cell sensitivity to cytotoxic T lymphocytes","volume":"12","author":"Poschel","year":"2023","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.lungcan.2026.109650_b0290","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1159\/000495399","article-title":"Interferon consensus sequence-binding protein 8, a tumor suppressor, suppresses tumor growth and invasion of non-small cell lung cancer by interacting with the Wnt\/beta-catenin pathway","volume":"51","author":"Ye","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109650_b0295","doi-asserted-by":"crossref","first-page":"9565","DOI":"10.1038\/s41598-025-94424-0","article-title":"Modulation of the tumor immune microenvironment by interferon regulatory factor 8 enhances immunotherapy in lung adenocarcinoma","volume":"15","author":"Huo","year":"2025","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.lungcan.2026.109650_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101353","article-title":"Engineered variants of the Ras effector protein RASSF5 (NORE1A) promote anticancer activities in lung adenocarcinoma","volume":"297","author":"Singh","year":"2021","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.lungcan.2026.109650_b0305","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1083\/jcb.201408087","article-title":"NORE1A is a Ras senescence effector that controls the apoptotic\/senescent balance of p53 via HIPK2","volume":"208","author":"Donninger","year":"2015","journal-title":"J. Cell Biol."},{"issue":"45","key":"10.1016\/j.lungcan.2026.109650_b0310","doi-asserted-by":"crossref","first-page":"35029","DOI":"10.1074\/jbc.M110.165506","article-title":"Tumor suppressor Ras association domain family 5 (RASSF5\/NORE1) mediates death receptor ligand-induced apoptosis","volume":"285","author":"Park","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.lungcan.2026.109650_b0315","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1038\/s44319-024-00203-9","article-title":"Complex interplay between RAS GTPases and RASSF effectors regulates subcellular localization of YAP","volume":"25","author":"Singh","year":"2024","journal-title":"EMBO Rep."},{"key":"10.1016\/j.lungcan.2026.109650_b0320","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.semcdb.2016.06.007","article-title":"Ras signaling through RASSF proteins","volume":"58","author":"Donninger","year":"2016","journal-title":"Semin. Cell Dev. Biol."},{"issue":"4","key":"10.1016\/j.lungcan.2026.109650_b0325","doi-asserted-by":"crossref","first-page":"e340","DOI":"10.1002\/mco2.340","article-title":"YAP\/TAZ: molecular pathway and disease therapy","volume":"4","author":"Wei","year":"2023","journal-title":"MedComm"},{"issue":"1","key":"10.1016\/j.lungcan.2026.109650_b0330","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1038\/s41467-024-46531-1","article-title":"Expected and unexpected effects after systemic inhibition of Hippo transcriptional output in cancer","volume":"15","author":"Baroja","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109650_b0335","first-page":"9","article-title":"YAP\/TAZ as master regulators in cancer: modulation, function and therapeutic approaches","volume":"4","author":"Piccolo","year":"2023","journal-title":"Nat. Cancer"},{"issue":"4","key":"10.1016\/j.lungcan.2026.109650_b0340","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1158\/1078-0432.CCR-10-2634","article-title":"Principles and current strategies for targeting autophagy for cancer treatment","volume":"17","author":"Amaravadi","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.lungcan.2026.109650_b0345","doi-asserted-by":"crossref","first-page":"e838","DOI":"10.1038\/cddis.2013.350","article-title":"Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment","volume":"4","author":"Sui","year":"2013","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109650_b0350","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s12672-025-02195-x","article-title":"Role of M2 macrophage-derived exosomes in cancer drug resistance via noncoding RNAs","volume":"16","author":"Hu","year":"2025","journal-title":"Discov. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109650_b0355","doi-asserted-by":"crossref","first-page":"9829","DOI":"10.1038\/s41598-026-39262-4","article-title":"M2 macrophage-derived extracellular vesicles induce EMT-like transcriptional reprogramming in colorectal cancer cells via upregulation of FAM83A","volume":"16","author":"Isik","year":"2026","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.lungcan.2026.109650_b0360","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/1873-3468.12108","article-title":"MicroRNA-495 regulates starvation-induced autophagy by targeting ATG3","volume":"590","author":"Li","year":"2016","journal-title":"FEBS Lett."},{"key":"10.1016\/j.lungcan.2026.109650_b0365","doi-asserted-by":"crossref","DOI":"10.1093\/burnst\/tkad058","article-title":"Exosomal miR-4645-5p from hypoxic bone marrow mesenchymal stem cells facilitates diabetic wound healing by restoring keratinocyte autophagy","volume":"12","author":"Shi","year":"2024","journal-title":"Burns Trauma"},{"key":"10.1016\/j.lungcan.2026.109650_b0370","doi-asserted-by":"crossref","DOI":"10.1093\/burnst\/tkae042","article-title":"Dexmedetomidine regulates exosomal miR-29b-3p from macrophages and alleviates septic myocardial injury by promoting autophagy in cardiomyocytes via targeting glycogen synthase kinase 3\u03b2","volume":"12","author":"Yu","year":"2024","journal-title":"Burns Trauma"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226007117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226007117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:29:05Z","timestamp":1792790945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500226007117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":74,"alternative-id":["S0169500226007117"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109650","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exosomal miR-3662 originating from M2-polarized macrophages facilitates cisplatin resistance of lung adenocarcinoma cells through inhibiting the IRF8\/RASSF5 cascade and boosting autophagy","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109650","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109650"}}